$AURX News
Last published 2mo ago
- 2mo agoAURXNuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswireDifferentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term Growth HOUSTON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB:AURX) ("Nuo"), a commercial-stage medical
- 6mo agoAURXNuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswireHOUSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB:AURX) ("Nuo"), a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care,
- 1y agoAURXSNNNuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+NephewGlobeNewswireHOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB:AURX) ("Nuo"), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in
- 1y agoAURXNuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing TherapiesGlobeNewswireHOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate chronic wound healing.
- 3y agoAURXNuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology ExchangeGlobeNewswireHOUSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB:AURX) ("Nuo"), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in
- 3y agoAURXNuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care AdvantageGlobeNewswireHOUSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB:AURX) ("Nuo"), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in
- 4y agoAURXNuo Therapeutics Provides Corporate and Business UpdateGlobeNewswireBroad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase Favorable initial progress on establishing substantive distribution network in support of commercial goals for Aurix Foundational Aurix produc
- 5y agoAURXNuo Therapeutics Announces Publication of Final Decision Memo for Autologous Blood Derived Products for Chronic Non-Healing Wounds by Centers for Medicare & Medicaid ServicesPR NewswireHOUSTON, April 20, 2021 /PRNewswire/ -- Nuo Therapeutics, Inc. (OTC:AURX) ("Nuo" or the "Company"), today announced the recent publication of the final decision memo for Autologous Blood-Derived Products for Chronic Non-Healing Wounds (CAG-00190R4). O